Page last updated: 2024-10-24

caffeine and Infarction, Middle Cerebral Artery

caffeine has been researched along with Infarction, Middle Cerebral Artery in 8 studies

Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.

Research Excerpts

ExcerptRelevanceReference
"Cerebral ischemic model was made by middle cerebral artery occlusion (MCAO)."1.35Aberration of L-type calcium channel in cardiac myocytes is one of the mechanisms of arrhythmia induced by cerebral ischemia. ( Du, J; Pan, G; Sun, L; Wang, L; Yang, B; Zhang, G; Zhang, Y, 2008)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Redondo, M1
Zarruk, JG1
Ceballos, P1
Pérez, DI1
Pérez, C1
Perez-Castillo, A1
Moro, MA1
Brea, J1
Val, C1
Cadavid, MI1
Loza, MI1
Campillo, NE1
Martínez, A1
Gil, C1
Fronz, U1
Deten, A1
Baumann, F1
Kranz, A1
Weidlich, S1
Härtig, W1
Nieber, K1
Boltze, J1
Wagner, DC1
Sun, L1
Du, J1
Zhang, G1
Zhang, Y2
Pan, G1
Wang, L1
Yang, B1
Aronowski, J3
Strong, R3
Shirzadi, A1
Grotta, JC4
Piriyawat, P1
Labiche, LA1
Burgin, WS1
Aronowski, JA1
Belayev, L1
Khoutorova, L1
Belayev, A1
Zhao, W1
Busto, R1
Ginsberg, MD1
Zhao, X1
Liu, SJ1
Zhang, J1

Trials

1 trial available for caffeine and Infarction, Middle Cerebral Artery

ArticleYear
Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke.
    Stroke, 2003, Volume: 34, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Caffeine; Cerebral Hemorrhage; Drug Therapy, Combina

2003

Other Studies

7 other studies available for caffeine and Infarction, Middle Cerebral Artery

ArticleYear
Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model.
    European journal of medicinal chemistry, 2012, Volume: 47, Issue:1

    Topics: Animals; Blood-Brain Barrier; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 7; Disease

2012
Continuous adenosine A2A receptor antagonism after focal cerebral ischemia in spontaneously hypertensive rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2014, Volume: 387, Issue:2

    Topics: Adenosine A2 Receptor Antagonists; Animals; Brain; Brain Ischemia; Caffeine; Infarction, Middle Cere

2014
Aberration of L-type calcium channel in cardiac myocytes is one of the mechanisms of arrhythmia induced by cerebral ischemia.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2008, Volume: 22, Issue:1-4

    Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Brain Ischemia; Caffeine; Calcium; Calcium Channel

2008
Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience.
    Stroke, 2003, Volume: 34, Issue:5

    Topics: Animals; Caffeine; Carotid Artery Thrombosis; Carotid Artery, Common; Cerebral Hemorrhage; Combined

2003
Caffeinol confers cortical but not subcortical neuroprotection after transient focal cerebral ischemia in rats.
    Brain research, 2004, May-22, Volume: 1008, Issue:2

    Topics: Animals; Behavior, Animal; Caffeine; Cerebral Cortex; Dose-Response Relationship, Drug; Ethanol; Inf

2004
Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats.
    Stroke, 2005, Volume: 36, Issue:1

    Topics: Animals; Behavior, Animal; Caffeine; Drug Combinations; Drug Therapy, Combination; Ethanol; Infarcti

2005
Combination of low dose ethanol and caffeine protects brain from damage produced by focal ischemia in rats.
    Neuropharmacology, 2000, Jan-28, Volume: 39, Issue:3

    Topics: Animals; Blood Glucose; Blood Pressure; Caffeine; Central Nervous System Depressants; Central Nervou

2000